Annual Revenue
$113.31 M
+$109.66 M+3005.10%
December 31, 2023
Summary
- As of February 7, 2025, WVE annual revenue is $113.31 million, with the most recent change of +$109.66 million (+3005.10%) on December 31, 2023.
- During the last 3 years, WVE annual revenue has risen by +$93.23 million (+464.35%).
- WVE annual revenue is now at all-time high.
Performance
WVE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
-$7.68 M
-$27.37 M-138.98%
September 30, 2024
Summary
- As of February 7, 2025, WVE quarterly revenue is -$7.68 million, with the most recent change of -$27.37 million (-138.98%) on September 30, 2024.
- Over the past year, WVE quarterly revenue has dropped by -$36.73 million (-126.42%).
- WVE quarterly revenue is now -115.60% below its all-time high of $49.21 million, reached on September 30, 2023.
Performance
WVE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$53.61 M
-$56.89 M-51.48%
September 30, 2024
Summary
- As of February 7, 2025, WVE TTM revenue is $53.61 million, with the most recent change of -$56.89 million (-51.48%) on September 30, 2024.
- Over the past year, WVE TTM revenue has dropped by -$59.70 million (-52.69%).
- WVE TTM revenue is now -52.69% below its all-time high of $113.31 million, reached on December 31, 2023.
Performance
WVE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
WVE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3005.1% | -126.4% | -52.7% |
| 3 y3 years | +464.4% | -126.4% | -52.7% |
| 5 y5 years | +686.1% | -126.4% | -52.7% |
WVE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3005.1% | -115.6% | at low | -52.7% | +1369.2% |
| 5 y | 5-year | at high | +3005.1% | -115.6% | at low | -52.7% | +1369.2% |
| alltime | all time | at high | >+9999.0% | -115.6% | at low | -52.7% | >+9999.0% |
Wave Life Sciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.68 M(-139.0%) | $53.61 M(-51.5%) |
| Jun 2024 | - | $19.69 M(+57.1%) | $110.50 M(-2.1%) |
| Mar 2024 | - | $12.54 M(-56.8%) | $112.91 M(-0.3%) |
| Dec 2023 | $113.31 M(+3005.1%) | $29.06 M(-41.0%) | $113.31 M(+32.5%) |
| Sep 2023 | - | $49.21 M(+122.6%) | $85.49 M(+133.8%) |
| Jun 2023 | - | $22.11 M(+71.0%) | $36.56 M(+146.6%) |
| Mar 2023 | - | $12.93 M(+943.5%) | $14.83 M(+306.4%) |
| Dec 2022 | $3.65 M(-91.1%) | $1.24 M(+334.7%) | $3.65 M(-12.6%) |
| Sep 2022 | - | $285.00 K(-24.0%) | $4.17 M(-89.6%) |
| Jun 2022 | - | $375.00 K(-78.6%) | $40.31 M(-5.6%) |
| Mar 2022 | - | $1.75 M(-0.8%) | $42.71 M(+4.3%) |
| Dec 2021 | $40.96 M(+104.0%) | $1.76 M(-95.2%) | $40.96 M(-15.8%) |
| Sep 2021 | - | $36.42 M(+1212.1%) | $48.64 M(+210.5%) |
| Jun 2021 | - | $2.78 M(-70.6%) | $15.66 M(-22.0%) |
| Dec 2020 | $20.08 M(+25.6%) | $9.44 M(+173.6%) | $20.08 M(+54.0%) |
| Sep 2020 | - | $3.45 M(+14.0%) | $13.04 M(+4.2%) |
| Jun 2020 | - | $3.03 M(-27.3%) | $12.52 M(-26.9%) |
| Mar 2020 | - | $4.16 M(+73.4%) | $17.12 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $15.98 M(+10.9%) | $2.40 M(-18.1%) | $15.98 M(-7.1%) |
| Sep 2019 | - | $2.93 M(-61.6%) | $17.20 M(-8.3%) |
| Jun 2019 | - | $7.63 M(+152.1%) | $18.77 M(+17.2%) |
| Mar 2019 | - | $3.03 M(-16.4%) | $16.02 M(+11.1%) |
| Dec 2018 | $14.41 M(+270.3%) | $3.62 M(-19.4%) | $14.41 M(+21.2%) |
| Sep 2018 | - | $4.49 M(-7.9%) | $11.89 M(+36.5%) |
| Jun 2018 | - | $4.88 M(+243.1%) | $8.71 M(+76.7%) |
| Mar 2018 | - | $1.42 M(+29.5%) | $4.93 M(+26.7%) |
| Dec 2017 | $3.89 M(+256.5%) | $1.10 M(-16.5%) | $3.89 M(+26.5%) |
| Sep 2017 | - | $1.31 M(+19.9%) | $3.08 M(+42.8%) |
| Jun 2017 | - | $1.10 M(+186.4%) | $2.15 M(+46.1%) |
| Mar 2017 | - | $383.00 K(+35.3%) | $1.48 M(+35.1%) |
| Dec 2016 | $1.09 M(+618.4%) | $283.00 K(-27.8%) | $1.09 M(+35.0%) |
| Sep 2016 | - | $392.00 K(-6.0%) | $809.00 K(+94.0%) |
| Jun 2016 | - | $417.00 K(+231.0%) | $417.00 K(+174.3%) |
| Dec 2015 | $152.00 K | - | - |
| Jun 2015 | - | $126.00 K(+384.6%) | $152.00 K(+484.6%) |
| Mar 2015 | - | $26.00 K | $26.00 K |
FAQ
- What is Wave Life Sciences annual revenue?
- What is the all time high annual revenue for Wave Life Sciences?
- What is Wave Life Sciences annual revenue year-on-year change?
- What is Wave Life Sciences quarterly revenue?
- What is the all time high quarterly revenue for Wave Life Sciences?
- What is Wave Life Sciences quarterly revenue year-on-year change?
- What is Wave Life Sciences TTM revenue?
- What is the all time high TTM revenue for Wave Life Sciences?
- What is Wave Life Sciences TTM revenue year-on-year change?
What is Wave Life Sciences annual revenue?
The current annual revenue of WVE is $113.31 M
What is the all time high annual revenue for Wave Life Sciences?
Wave Life Sciences all-time high annual revenue is $113.31 M
What is Wave Life Sciences annual revenue year-on-year change?
Over the past year, WVE annual revenue has changed by +$109.66 M (+3005.10%)
What is Wave Life Sciences quarterly revenue?
The current quarterly revenue of WVE is -$7.68 M
What is the all time high quarterly revenue for Wave Life Sciences?
Wave Life Sciences all-time high quarterly revenue is $49.21 M
What is Wave Life Sciences quarterly revenue year-on-year change?
Over the past year, WVE quarterly revenue has changed by -$36.73 M (-126.42%)
What is Wave Life Sciences TTM revenue?
The current TTM revenue of WVE is $53.61 M
What is the all time high TTM revenue for Wave Life Sciences?
Wave Life Sciences all-time high TTM revenue is $113.31 M
What is Wave Life Sciences TTM revenue year-on-year change?
Over the past year, WVE TTM revenue has changed by -$59.70 M (-52.69%)